Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Indigo Diabetes Raises €7M in Investment

Mar 2017
GENTBRUGGE, Belgium — Silicon photonic startup Indigo Diabetes NV has closed a €7 million ($7.4 million) round of series A investment to support its development of an optical glucose monitor for diabetics.

Single-chip glucose sensor.
Single-chip glucose sensor. Courtesy of Indigo Diabetes NV.

The company aims to use research from Ghent University and the imec electronics development center to replace conventional finger-prick blood tests with an implantable optical device.

“Licensing a series of new technologies from globally recognized research institutions UGent and imec enables Indigo to enter the market with the first needle-free and calibration-free glucose sensor,” said Danaë Delbeke, founder of Indigo and member of the Photonics Research Group at Ghent.

Thuja Capital is the lead investor.

Indigo Diabetesglucose monitorEuropeBusinessBiophotonicsSensors & DetectorsRapidScan

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!